Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
The Lancet Infectious Diseases2014Vol. 14(11), pp. 1090–1095
Citations Over TimeTop 1% of 2014 papers
Ali S. Omrani, Mustafa Saad, Kamran Baig, Abdelkarim Bahloul, Mohammed Abdul-Matin, Amal Y.A. Al-Aidaroos, Ghaleb A Almakhlafi, Mohammed M. Albarrak, Ziad A. Memish, Ali Albarrak
Related Papers
- → Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C(2009)17 cited
- → The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection(2007)3 cited
- Therapeutic Effect of Ribavirin on Bronchiolitis by Three Kinds of Medication(2009)
- In vitro inhibition of respiratory syncytial virus with combined ribavirin and kechuanping(2005)
- → The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection(2006)